Conquering Diseases

Study Of A Targeted Investigational Drug For Non-Small Cell Lung Cancer That Has Come Back Or Spread After Treatment

Description

Seeking men and women whose non-small cell lung cancer has come back or spread after treatment for a study of an investigational drug that is targeted for tumors with a specific biologic marker.

Overview

We are studying whether the investigational drug is safe and effective in reducing the growth or spread of non-small cell lung cancer in people whose tumor has a specific genetic biomarker. We are evaluating whether the investigational drug could shrink your cancer and if the biomarker test is helpful in deciding which drugs to prescribe.

What we're hoping for

Evaluate the safety and effectiveness of an investigational drug in reducing the growth or spread of advanced non-small cell lung cancer in people who have RET Fusion-Positive tumors.

Additional Information

ClinicalTrials.gov Identifier: NCT04268550

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989